March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
May 15, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
October 6, 2021 – Biosense Webster announced the first cases using a radiofrequency balloon ablation catheter were ...
October 6, 2020 – The U.S. Food and Drug Administration (FDA) cleared the Biosense Webster ThermoCool SmartTouch SF ...
September 3, 2020 – Biosense Webster launched its Carto 3 System Version 7 and the Carto Prime Mapping Module to enhance ...
May 21, 2018 — The available electrophysiology catheter ablation technologies are not designed for use in the ...
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve ...
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigational ...
August 15, 2016 — The U.S. Food and Drug Administration has granted market approval for the Biosense Webster Thermocool ...
November 24, 2015 — Biosense Webster announced it has acquired Coherex Medical Inc., a privately held medical device ...